Metal exposure and Alzheimer's pathogenesis

Journal of Structural Biology

Volumn 155, Issue 1, 2006, Pages 45-51

  Liu, Guijian ^a   Huang, Weidong ^a   Moir, Robert D ^b   Vanderburg, Charles R ^b   Lai, Barry ^c   Peng, Zicheng ^a   Tanzi, Rudolph E ^b   Rogers, Jack T ^b   Huang, Xudong ^b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c ARGONNE NATIONAL LABORATORY   (United States)

Author keywords

A amyloidosis; Alzheimer's disease; Amyloid precursor protein; Laser capture microdissection; Metal; X ray fluorescence microscopy

Indexed keywords

AMYLOID BETA PROTEIN; CLIOQUINOL; DEFEROXAMINE; METAL; METAL CHELATE;

ALZHEIMER DISEASE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD BRAIN BARRIER; BRAIN TISSUE; LASER CAPTURE MICRODISSECTION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OLIGOMERIZATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHARMACOPHORE; PRIORITY JOURNAL; PROTEIN AGGREGATION; SENILE PLAQUE; SHORT SURVEY; X RAY FLUORESCENCE;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID NEUROPATHIES; ANIMALS; BRAIN; ENVIRONMENTAL EXPOSURE; HUMANS; METALS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; RISK FACTORS; TRACE ELEMENTS;

EID: 33745112857     PISSN: 10478477     EISSN: 10958657     Source Type: Journal    
DOI: 10.1016/j.jsb.2005.12.011     Document Type: Short Survey

References (67)

1. Atwood C.S., Moir R.D., Huang X., Scarpa R.C., Bacarra N.M., Romano D.M., Hartshorn M.A., Tanzi R.E., and Bush A.I. Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem. 273 (1998) 12817-12826
2. Basha M.R., Wei W., Bakheet S.A., Benitez N., Siddiqi H.K., Ge Y.W., Lahiri D.K., and Zawia N.H. The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain. J. Neurosci. 25 (2005) 823-829
3. Bayer T.A., Schafer S., Simons A., Kemmling A., Kamer T., Tepest R., Eckert A., Schussel K., Eikenberg O., Sturchler-Pierrat C., Abramowski D., Staufenbiel M., and Multhaup G. Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice. Proc. Natl. Acad. Sci. USA 100 (2003) 14187-14192
4. Becaria A., Bondy S.C., and Campbell A. Aluminum and copper interact in the promotion of oxidative but not inflammatory events: implications for Alzheimer's disease. J. Alzheimers Dis. 5 (2003) 31-38
5. Bellingham S.A., Ciccotosto G.D., Needham B.E., Fodero L.R., White A.R., Masters C.L., Cappai R., and Camakaris J. Gene knockout of amyloid precursor protein and amyloid precursor-like protein-2 increases cellular copper levels in primary mouse cortical neurons and embryonic fibroblasts. J. Neurochem. 91 (2004) 423-428
6. Bellingham S.A., Lahiri D.K., Maloney B., La Fontaine S., Multhaup G., and Camakaris J. Copper depletion down-regulates expression of the Alzheimer's disease amyloid-beta precursor protein gene. J. Biol. Chem. 279 (2004) 20378-20386
7. Bonner R.F., Emmert-Buck M., Cole K., Pohida T., Chuaqui R., Goldstein S., and Liotta L.A. Laser capture microdissection: molecular analysis of tissue. Science 278 (1997) 1481-1483
8. Bush A.I., Pettingell W.H., Multhaup G., Paradis M.d., Vonsattel J.-P., Gusella J.F., Beyreuther K., Masters C.L., and Tanzi R.E. Rapid induction of Alzheimer Aβ amyloid formation by zinc. Science 265 (1994) 1464-1467
9. Cherny R.A., Atwood C.S., Xilinas M.E., Gray D.N., Jones W.D., McLean C.A., Barnham K.J., Volitakis I., Fraser F.W., Kim Y., Huang X., Goldstein L.E., Moir R.D., Lim J.T., Beyreuther K., Zheng H., Tanzi R.E., Masters C.L., and Bush A.I. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30 (2001) 665-676
10. Cherny R.A., Legg J.T., McLean C.A., Fairlie D.P., Huang X., Atwood C.S., Beyreuther K., Tanzi R.E., Masters C.L., and Bush A.I. Aqueous dissolution of Alzheimer's disease Aβ amyloid deposits by biometal depletion. J. Biol. Chem. 274 (1999) 23223-23228
11. Colangelo V., Schurr J., Ball M.J., Pelaez R.P., Bazan N.G., and Lukiw W.J. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J. Neurosci. Res. 70 (2002) 462-473
12. Crapper McLachlan D.R., Dalton A.J., Kruck T.P.A., Bell M.Y., Smith W.L., Kalow W., and Andrews D.F. Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 337 (1991) 1304-1308
13. Cuajungco M.P., Goldstein L.E., Nunomura A., Smith M.A., Lim J.T., Atwood C.S., Huang X., Farrag Y.W., Perry G., and Bush A.I. Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc. J. Biol. Chem. 275 (2000) 19439-19442
14. Cummings J.L., Vinters H.V., Cole G.M., and Khachaturian Z.S. Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology 51S (1998) S2-S17
15. Curtain C.C., Ali F., Volitakis I., Cherny R.A., Norton R.S., Beyreuther K., Barrow C.J., Masters C.L., Bush A.I., and Barnham K.J. Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J. Biol. Chem. 276 (2001) 20466-20473
16. Dedeoglu A., Cormier K., Payton S., Tseitlin K.A., Kremsky J.N., Lai L., Li X., Moir R.D., Tanzi R.E., Bush A.I., Kowall N.W., Rogers J.T., and Huang X. Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis. Exp. Gerontol. 39 (2004) 1641-1649
17. Dikalov S.I., Vitek M.P., Maples K.R., and Mason R.P. Amyloid β peptides do not form peptide-derived free radicals spontaneously, but can enhance metal-catalyzed oxidation of hydroxylamines to nitroxides. J. Biol. Chem. 274 (1999) 9392-9399
18. Dikalov S.I., Vitek M.P., and Mason R.P. Cupric-amyloid beta peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical. Free Radic. Biol. Med. 36 (2004) 340-347
19. Emmert-Buck M.R., Bonner R.F., Smith P.D., Chuaqui R.F., Zhuang Z., Goldstein S.R., Weiss R.A., and Liotta L.A. Laser capture microdissection [see comments]. Science 274 (1996) 998-1001
20. Giustarini D., Rossi R., Milzani A., Colombo R., and Dalle-Donne I. S-glutathionylation: from redox regulation of protein functions to human diseases. J. Cell. Mol. Med. 8 (2004) 201-212
21. Glenner G.G., and Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120 (1984) 885-890
22. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
23. Hebert L.E., Scherr P.A., Bienias J.L., Bennett D.A., and Evans D.A. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch. Neurol. 60 (2003) 1119-1122
24. Huang X., Atwood C.S., Hartshorn M.A., Multhaup G., Goldstein L.E., Scrapa S.C., Cuajungco M.P., Gray D.N., Lim J., Moir R.D., Tanzi R.E., and Bush A.I. The Aβ peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38 (1999) 7609-7616
25. Huang X., Atwood C.S., Moir R.D., Hartshorn M.A., Tanzi R.E., and Bush A.I. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides. J. Biol. Inorg. Chem. 9 (2004) 954-960
26. Huang X., Atwood C.S., Moir R.D., Hartshorn M.A., Vonsattel J.P., Tanzi R.E., and Bush A.I. Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors. J. Biol. Chem. 272 (1997) 26464-26470
27. Huang X., Cuajungco M.P., Atwood C.S., Hartshorn M.A., Tyndall J., Hanson G.R., Stokes K.C., Leopold M., Multhaup G., Goldstein L.E., Scarpa R.C., Saunders A.J., Lim J., Moir R.D., Glabe C., Bowden E.F., Masters C.L., Fairlie D.P., Tanzi R.E., and Bush A.I. Cu(II) potentiation of Alzheimer Aβ neurotoxicity: correlation with cell-free hydrogen peroxide production and metal reduction. J. Biol. Chem. 274 (1999) 37111-37116
28. Huang X., Moir R.D., Tanzi R.E., Bush A.I., and Rogers J.T. Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann. NY Acad. Sci. 1012 (2004) 153-163
29. Hyman M.H. The impact of mercury on human health and the environment. Altern. Ther. Health Med. 10 (2004) 70-75
30. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., and Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325 (1987) 733-736
31. Karr J.W., Akintoye H., Kaupp L.J., and Szalai V.A. N-Terminal deletions modify the Cu2+ binding site in amyloid-beta. Biochemistry 44 (2005) 5478-5487
32. 2+ in a mononuclear metal ion binding site. J. Am. Chem. Soc. 126 (2004) 13534-13538
33. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., and Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300 (2003) 486-489
34. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., Morgan T.E., Rozovsky I., Trommer B., Viola K.L., Wals P., Zhang C., Finch C.E., Krafft G.A., and Klein W.L. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95 (1998) 6448-6453
35. Lee J.Y., Cole T.B., Palmiter R.D., Suh S.W., and Koh J.Y. Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc. Natl. Acad. Sci. USA 99 (2002) 7705-7710
36. Lorenzo A., and Yankner B.A. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl. Acad. Sci. USA 91 (1994) 12243-12247
37. Loring J.F., Wen X., Lee J.M., Seilhamer J., and Somogyi R. A gene expression profile of Alzheimer's disease. DNA Cell Biol. 20 (2001) 683-695
38. Lovell M.A., Robertson J.D., Teesdale W.J., Campbell J.L., and Markesbery W.R. Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158 (1998) 47-52
39. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., and Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82 (1985) 4245-4249
40. Morgan D.M., Dong J., Jacob J., Lu K., Apkarian R.P., Thiyagarajan P., and Lynn D.G. Metal switch for amyloid formation: insight into the structure of the nucleus. J. Am. Chem. Soc. 124 (2002) 12644-12645
41. Multhaup G., Schlicksupp A., Hesse L., Beher D., Ruppert T., Masters C.L., and Beyreuther K. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science 271 (1996) 1406-1409
42. 2. J. Biol. Chem. 277 (2002) 40302-40308
43. Ortega R. Chemical elements distribution in cells. Nucl. Instr. Meth. Phys. Res. B231 (2005) 218-223
44. Phinney A.L., Drisaldi B., Schmidt S.D., Lugowski S., Coronado V., Liang Y., Horne P., Yang J., Sekoulidis J., Coomaraswamy J., Chishti M.A., Cox D.W., Mathews P.M., Nixon R.A., Carlson G.A., St George-Hyslop P., and Westaway D. In vivo reduction of amyloid-beta by a mutant copper transporter. Proc. Natl. Acad. Sci. USA 100 (2003) 14193-14198
45. Pike C.J., Walencewicz A.J., Glabe C.G., and Cotman C.W. In vitro aging of β amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563 (1991) 311-314
46. Prelli F., Castano E.M., van Duinen S.G., Bots G.T., Luyendijk W., and Frangione B. Different processing of Alzheimer's beta-protein precursor in the vessel wall of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type. Biochem. Biophys. Res. Commun. 151 (1988) 1150-1155
47. Regland B., Lehmann W., Abedini I., Blennow K., Jonsson M., Karlsson I., Sjogren M., Wallin A., Xilinas M., and Gottfries C.G. Treatment of Alzheimer's disease with clioquinol. Dement. Geriatr. Cogn. Disord. 12 (2001) 408-414
48. Ritchie C.W., Bush A.I., Mackinnon A., Macfarlane S., Mastwyk M., MacGregor L., Kiers L., Cherny R., Li Q.X., Tammer A., Carrington D., Mavros C., Volitakis I., Xilinas M., Ames D., Davis S., Beyreuther K., Tanzi R.E., and Masters C.L. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch. Neurol. 60 (2003) 1685-1691
49. Robakis N.K., Wisniewski H.M., Jenkins E.C., Devine-Gage E.A., Houck G.E., Yao X.L., Ramakrishna N., Wolfe G., Silverman W.P., and Brown W.T. Chromosome 21q21 sublocalisation of gene encoding β amyloid peptide in cerebral vessels and neuritic (senile) plaques of people with Alzheimer disease and Down syndrome [letter]. Lancet 1 (1987) 384-385
50. Rogers J.T., and Lahiri D.K. Metal and inflammatory targets for Alzheimer's disease. Curr. Drug Targets 5 (2004) 535-551
51. Rogers J.T., Randall J.D., Cahill C.M., Eder P.S., Huang X., Gunshin H., Leiter L., McPhee J., Sarang S.S., Utsuki T., Greig N.H., Lahiri D.K., Tanzi R.E., Bush A.I., Giordano T., and Gullans S.R. An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript. J. Biol. Chem. 277 (2002) 45518-45528
52. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81 (2001) 741-766
53. Sengupta P., Garai K., Sahoo B., Shi Y., Callaway D.J., and Maiti S. The amyloid beta peptide (Abeta(1-40)) is thermodynamically soluble at physiological concentrations. Biochemistry 42 (2003) 10506-10513
54. Smith M.A., Perry G., Richey P.L., Sayre L.M., Anderson V.E., Beal M.F., and Kowall N. Oxidative damage in Alzheimer's. Nature 382 (1996) 120-121
55. Sparks D.L., and Schreurs B.G. Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 100 (2003) 11065-11069
56. Syme C.D., Nadal R.C., Rigby S.E., and Viles J.H. Copper binding to the amyloid-beta (Abeta) peptide associated with Alzheimer's disease: folding, coordination geometry, pH dependence, stoichiometry, and affinity of Abeta-(1-28): insights from a range of complementary spectroscopic techniques. J. Biol. Chem. 279 (2004) 18169-18177
57. Tanzi R.E., and Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120 (2005) 545-555
58. Tanzi R.E., Gusella J.F., Watkins P.C., Bruns G.A., St George-Hyslop P., Van Keuren M.L., Patterson D., Pagan S., Kurnit D.M., and Neve R.L. Amyloid β protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235 (1987) 880-884
59. Tanzi R.E., McClatchey A.I., Lamperti E.D., Villa-Komaroff L., Gusella J.F., and Neve R.L. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature 331 (1988) 528-530
60. Tanzi R.E., Moir R.D., and Wagner S.L. Clearance of Alzheimer's Abeta peptide: the many roads to perdition. Neuron 43 (2004) 605-608
61. Uchida Y., Takio K., Titani K., Ihara Y., and Tomonaga M. The growth-inhibitory factor that is deficient in the Alzheimer's disease brain is a 68-amino acid metallothionein-like protein. Neuron 7 (1991) 337-347
62. Vigo-Pelfrey C., Lee D., Keim P., Lieberburg I., and Schenk D.B. Characterization of β amyloid peptide from human cerebrospinal fluid. J. Neurochem. 61 (1993) 1965-1968
63. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., and Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 (2002) 535-539
64. White A.R., Huang X., Jobling M.F., Barrow C.J., Beyreuther K., Masters C.L., Bush A.I., and Cappai R. Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways. J. Neurochem. 76 (2001) 1509-1520
65. White A.R., Multhaup G., Maher F., Bellingham S., Camakaris J., Zheng H., Bush A.I., Beyreuther K., Masters C.L., and Cappai R. The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures. J. Neurosci. 19 (1999) 9170-9179
66. Yu W.H., Lukiw W.J., Bergeron C., Niznik H.B., and Fraser P.E. Metallothionein III is reduced in Alzheimer's disease. Brain Res. 894 (2001) 37-45
67. Zlokovic B.V. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci. 28 (2005) 202-208